Search Within

Mark Yungjie Jeng

Formats
  1. Journal Article (3)
  2. Editorial (2)
  3. Meeting Abstract (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (7)
  2. Hematology-Oncology Fellows (7)
  3. Solid Tumor Oncology Division (6)
  4. Thoracic Oncology (6)
  5. Weinberg Fellows (5)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Adam Schoenfeld (3)
  2. Helena Yu (3)
  3. Mark Kris (2)
  4. Adrienne Boire (1)
  5. Afsana Rahman (1)
  6. Ann Jakubowski (1)

More People

Years
  1. 2025 (6)
  2. 2024 (1)
Publications
  1. Clinical Cancer Research (2)
  2. Journal of Clinical Oncology (2)
  3. Annals of Oncology (1)
  4. JCO Precision Oncology (1)
  5. Journal of Geriatric Oncology (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (1)
  4. Oxford University Press (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients
    Research Letter

    Jeng, M. Y.; Wong, P.; Flynn, J. R.; Ritter, E.; Ho, C.; Ruiz, J. D.; Jakubowski, A. A.; Papadopoulos, E. B.; Shaffer, B. C.; Ponce, D. R.; more...
    Journal of Geriatric Oncology (2025)

    Fulltext@MSK | Save
  • Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases
    Journal Article

    Wilcox, J. A.; Jeng, M. Y.; Tischfield, S.; Sui, J. S. Y.; Nemirovsky, D.; Heller, G.; Choudhury, N. J.; Ross, J. S.; Rudin, C. M.; Riely, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Use of a large language model (LLM) for pan-cancer automated detection of anti-cancer therapy toxicities and translational toxicity research
    Meeting Abstract

    Bakouny, Z.; Ahmed, N.; Fong, C.; Rahman, A.; Perea-Chamblee, T.; Pichotta, K.; Waters, M.; Fu, C.; Jeng, M. Y.; Lee, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced non-small cell lung cancer
    Journal Article

    Pecci, F.; Thummalapalli, R.; Alden, S. L.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Jeng, M.; Egger, J. V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
    Journal Article

    Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Can longitudinal biomarkers guide treatment decisions? Time will tell
    Editorial

    Jeng, M. Y.; Schoenfeld, A. J.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Leptomeningeal metastasis in the era of CNS-penetrant tyrosine kinase inhibitor therapy
    Editorial

    Jeng, M. Y.; Yu, H. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save